# Zebra Technologies Corp: overview

ZBRA · Nasdaq · CIK 877212 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zbra.md) · [Financials](/companies/zbra/financials.md) · [Filings](/companies/zbra/filings.md) · [Insiders](/companies/zbra/insiders.md)

Latest reported revenue: [$1.56bn](/filings/0001628280-26-052550.md) for Q2 FY2026, three months to 2026-07-04, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-052550).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,255](/filings/0001628280-25-046778.md) | [1,334 d](/filings/0001628280-26-007668.md) | [1,308](/filings/0001628280-26-034109.md) | [1,293](/filings/0001628280-26-052550.md) | [1,320](/filings/0001628280-25-046778.md) | [1,475 d](/filings/0001628280-26-007668.md) | [1,495](/filings/0001628280-26-034109.md) | [1,557](/filings/0001628280-26-052550.md) |
| Gross margin | % | [48.8%](/filings/0001628280-25-046778.md) | [48.6% d](/filings/0001628280-26-007668.md) | [49.3%](/filings/0001628280-26-034109.md) | [47.6%](/filings/0001628280-26-052550.md) | [48.0%](/filings/0001628280-25-046778.md) | [47.3% d](/filings/0001628280-26-007668.md) | [49.6%](/filings/0001628280-26-034109.md) | [53.0%](/filings/0001628280-26-052550.md) |
| Operating margin | % | [15.2%](/filings/0001628280-25-046778.md) | [16.9% d](/filings/0001628280-26-007668.md) | [14.9%](/filings/0001628280-26-034109.md) | [14.2%](/filings/0001628280-26-052550.md) | [13.9%](/filings/0001628280-25-046778.md) | [9.4% d](/filings/0001628280-26-007668.md) | [14.4%](/filings/0001628280-26-034109.md) | [20.6%](/filings/0001628280-26-052550.md) |
| Net margin | % | [10.9%](/filings/0001628280-25-046778.md) | [12.2% d](/filings/0001628280-26-007668.md) | [10.4%](/filings/0001628280-26-052550.md) | [8.7%](/filings/0001628280-26-052550.md) | [7.7%](/filings/0001628280-25-046778.md) | [4.7% d](/filings/0001628280-26-007668.md) | [9.0%](/filings/0001628280-26-052550.md) | [15.0%](/filings/0001628280-26-052550.md) |
| Diluted EPS | $ per share | [2.64](/filings/0001628280-25-046778.md) | not reported | [2.62](/filings/0001628280-26-034109.md) | [2.19](/filings/0001628280-26-052550.md) | [1.97](/filings/0001628280-25-046778.md) | not reported | [2.72](/filings/0001628280-26-034109.md) | [4.85](/filings/0001628280-26-052550.md) |
| Free cash flow | $m | [277 d](/filings/0001628280-25-046778.md) | [288 d](/filings/0001628280-26-007668.md) | [158](/filings/0001628280-26-034109.md) | [130 d](/filings/0001628280-26-052550.md) | [216 d](/filings/0001628280-25-046778.md) | [327 d](/filings/0001628280-26-007668.md) | [163](/filings/0001628280-26-034109.md) | [198 d](/filings/0001628280-26-052550.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,627](/filings/0000877212-24-000029.md) | [5,781](/filings/0000877212-25-000027.md) | [4,584](/filings/0001628280-26-007668.md) | [4,981](/filings/0001628280-26-007668.md) | [5,396](/filings/0001628280-26-007668.md) |
| Gross margin | % | [46.7%](/filings/0000877212-24-000029.md) | [45.4%](/filings/0000877212-25-000027.md) | [46.3%](/filings/0001628280-26-007668.md) | [48.4%](/filings/0001628280-26-007668.md) | [48.1%](/filings/0001628280-26-007668.md) |
| Operating margin | % | [17.4%](/filings/0000877212-24-000029.md) | [9.2%](/filings/0000877212-25-000027.md) | [10.5%](/filings/0001628280-26-007668.md) | [14.9%](/filings/0001628280-26-007668.md) | [13.0%](/filings/0001628280-26-007668.md) |
| Net margin | % | [14.9%](/filings/0000877212-24-000029.md) | [8.0%](/filings/0000877212-25-000027.md) | [6.5%](/filings/0001628280-26-007668.md) | [10.6%](/filings/0001628280-26-007668.md) | [7.8%](/filings/0001628280-26-007668.md) |
| Diluted EPS | $ per share | [15.52](/filings/0000877212-24-000029.md) | [8.80](/filings/0000877212-25-000027.md) | [5.72](/filings/0001628280-26-007668.md) | [10.18](/filings/0001628280-26-007668.md) | [8.18](/filings/0001628280-26-007668.md) |
| Free cash flow | $m | [1,010](/filings/0000877212-24-000029.md) | [413](/filings/0000877212-25-000027.md) | [(91.0)](/filings/0001628280-26-007668.md) | [954](/filings/0001628280-26-007668.md) | [831](/filings/0001628280-26-007668.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/zbra/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $871.8m | 3,311,526 |  | Reduced −891,446 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $819.9m | 3,114,262 |  | Reduced −86,743 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $702.2m | 2,667,369 |  | Reduced −135,546 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $689.1m | 2,617,838 |  | Added +1,147,064 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $496.2m | 1,884,644 |  | Reduced −273,038 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $464.9m | 1,765,967 |  | Added +236,405 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $355.2m | 1,351,501 |  | Added +11,712 |
| [Alyeska Investment Group, L.P.](/funds/1453072.md) | 2026-06-30 | $328.7m | 1,248,478 |  | Reduced −76,318 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $318.3m | 1,208,889 |  | Added +963,268 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $280.8m | 1,066,696 |  | Added +566,068 |

## Recent filings

[All 1,437 filings](/companies/zbra/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 16:07 ET | [10-Q](/filings/0001628280-26-052550.md) | Quarterly report, period 2026-07-04 | 0001628280-26-052550 |
| 2026-08-04 | 07:38 ET | [8-K](/filings/0001628280-26-052158.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052158 |
| 2026-05-26 | 16:04 ET | [8-K](/filings/0001628280-26-038066.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-038066 |
| 2026-05-12 | 16:11 ET | [10-Q](/filings/0001628280-26-034109.md) | Quarterly report, period 2026-04-04 | 0001628280-26-034109 |
| 2026-05-12 | 07:27 ET | [8-K](/filings/0001628280-26-033877.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-033877 |
| 2026-04-03 | 11:00 ET | [DEF 14A](/filings/0001104659-26-039488.md) | Proxy statement, period 2026-05-19 | 0001104659-26-039488 |
| 2026-02-12 | 16:07 ET | [10-K](/filings/0001628280-26-007668.md) | Annual report, period 2025-12-31 | 0001628280-26-007668 |
| 2026-02-12 | 07:48 ET | [8-K](/filings/0000877212-26-000003.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000877212-26-000003 |
| 2025-12-15 | 08:52 ET | [8-K](/filings/0001628280-25-056882.md) | 2.05 Exit or disposal costs; 2.06 Material impairments; 9.01 Financial statements and exhibits | 0001628280-25-056882 |
| 2025-11-24 | 08:53 ET | [8-K](/filings/0001628280-25-053699.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-053699 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-007668.md), filed Feb 12, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 877212
- Tickers: ZBRA
- Exchange: Nasdaq
- SIC code: 3560 General Industrial Machinery & Equipment
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.